PURASORB PLG 8560 Medical Device Lactide-Glycolide Copolymer is a medical-grade poly(L-lactide-co-glycolide) granulate supplied for melt processing into bioresorbable implants, surgical fixation devices, and controlled-release matrices. The product code identifies a lactide-rich copolymer with an 85:15 L-lactide:glycolide molar ratio and an inherent viscosity midpoint of 0.60 dL/g; the viscosity is determined in chloroform at 25 °C and a polymer concentration of 0.1 g/dL. The polymer is manufactured under a quality management system certified to ISO 13485:2016. As-supplied granulate is not an implantable finished material; biological evaluation is performed on the finished device under ISO 10993-1:2018. The copolymer degrades by bulk hydrolysis of ester linkages to lactic acid and glycolic acid, which are removed through normal metabolic pathways.

The lot certificate of analysis for the product typically reports residual lactide, residual glycolide, tin-containing catalyst residue, heavy-metal content, loss on drying, and inherent viscosity. Because the grade is intended for medical-device fabrication, the manufacturer’s specification for residual monomer and catalyst metal is tighter than for technical-grade PLG polymers; the specific lot should be qualified before process development. The product is supplied as white to off-white granules and should be stored in the original sealed aluminum-lined packaging at 2–8 °C to limit moisture uptake.

How Are the Monomer Ratio and Viscosity Specification Interpreted?

The 85:15 lactide-to-glycolide ratio is a composition specification rather than a direct measurement of block length distribution. The inherent viscosity midpoint of 0.60 dL/g is an indirect molecular weight indicator that is more robust for resorbable polyesters than gel-permeation chromatography when moisture conditioning varies among laboratories. A higher inherent viscosity, relative to lower-IV grades in the same copolymer family, corresponds to longer polymer chains, higher melt viscosity, and slower hydrolysis-driven mass loss. The amorphous glass transition of rapidly cooled test specimens is typically observed in the 50–60 °C range by differential scanning calorimetry according to ISO 11357-2:2020; no pronounced melt endotherm is expected unless the material is annealed.

Dilute-solution viscometry is typically performed according to ISO 1628-1:2021 or an equivalent supplier method; the result is reported as inherent viscosity rather than intrinsic viscosity unless reduced to zero concentration. When comparing lots, measurements should be normalized to the same solvent, temperature, and concentration because PLG copolymers are sensitive to chain entanglement in chloroform. Published data for this specific configuration is limited to the supplier specification and qualification studies performed by device manufacturers.

Thermal and Rheological Boundaries During Melt Conversion

Melt conversion of the granulate requires pre-drying to a residual moisture level of ≤0.025 wt% before extrusion or injection molding. Vacuum drying at 45 °C for 4–12 h or dehumidified-air drying with a dew point of −40 °C is used to avoid hydrolytic chain scission in the feed throat. Processing barrel temperatures between 160 °C and 190 °C are typical; temperatures above 200 °C accelerate random chain scission and lactide reformation. On a co-rotating twin-screw extruder with 25:1 to 40:1 L/D, the melt temperature should be monitored at the die rather than relying solely on barrel set points because viscous dissipation increases the actual polymer temperature.

Residence time at 180 °C should be kept below 10 min during compounding; longer heat histories lower inherent viscosity and broaden molecular weight distribution. In injection molding, gate diameters below 0.8 mm can produce excessive shear heating; free-flow hot-runner channels should be designed to eliminate dead volumes larger than approximately two shot volumes. Regrind use is generally restricted to validated levels and is not recommended for implantable devices because repeated melt cycles reduce molecular weight and alter degradation time.

Production-scale processing records show that melt-pressure drift at constant screw speed is often caused by residual moisture rather than raw-material lot change. When granulate is transferred from cold storage to a humid molding room without a vapor-tight container, condensation can raise surface moisture above the processing limit within minutes. Wet polymer produces silver streaks and gas bubbles in molded parts and causes an apparent increase in melt flow due to hydrolytic chain scission. A nitrogen purge on the feed throat and vacuum venting below −0.8 bar are used on extruders to remove residual water and low-molecular-weight volatiles. The polymer is incompatible with strong alkaline materials and unneutralized amine-functional additives; these contaminants accelerate hydrolysis during storage and processing.

When the 85:15 Lactide-Glycolide Copolymer Replaces 50:50 PLG in Load-Bearing Applications

Replacement of a 50:50 PLG with the 85:15 PLG grade shifts the hydrolytic degradation curve later because the reduced glycolide content decreases water uptake and lowers the density of fast-cleaving glycolate ester linkages. In in vitro phosphate-buffered saline at pH 7.4 and 37 °C, compression-molded or injection-molded articles made from lactide-rich PLG fractions retain measurable strength longer than equivalent 50:50 materials; however, the actual timeline depends on part thickness, porosity, and sterilization history. Published data for this specific configuration is limited for load-bearing applications, so device-specific testing under ISO 527-2:2012 or ASTM D638 is required.

Relative to lower-IV grades in the 85:15 PLG family, PLG 8560 provides higher melt viscosity and longer chain entanglement, which is beneficial for load-bearing screws, pins, and plates but can restrict filling of microfeatures. Lower-IV PLG grades are often preferred for solvent-based microsphere fabrication where low solution viscosity and rapid dissolution are desirable. Compared with poly(L-lactide) homopolymer, the glycolide units in PLG 8560 reduce crystallinity and shorten degradation time while retaining more initial stiffness than 50:50 PLG. The difference in degradation length is therefore one of degree, not mechanism; both materials degrade by bulk hydrolysis.

Regulatory acceptance of the grade for a specific device is established through the device dossier, not by stand-alone polymer approval. The manufacturer supports applicants with a medical device master file, chemical characterization data, and lot-specific certificates of analysis. For a finished implant, toxicological risk assessment under ISO 10993-1:2018 should address potential leachable oligomers, residual lactide and glycolide, tin catalyst residues, and any processing aids. Biological tests commonly used during qualification include ISO 10993-5:2009 cytotoxicity, ISO 10993-10:2010 irritation and sensitization, and ISO 10993-11:2017 systemic toxicity; the specific endpoints are selected based on device contact duration and tissue type.

Why Does the Monomer Sequence Distribution Influence Hydrolytic Stability?

The ring-opening polymerization of lactide and glycolide can produce segments that are not perfectly random because monomer reactivity ratios differ. Glycolide-rich blocks hydrate more readily than lactide-rich blocks, creating local zones of faster ester cleavage. In an 85:15 copolymer, glycolide-rich sequences are diluted, which slows the formation of interconnected hydrophilic channels that otherwise accelerate bulk water uptake. The degradation remains bulk-hydrolytic rather than surface-eroding; autocatalytic accumulation of acidic oligomers in the core can create a faster-degrading interior in thick parts above approximately 3 mm.

The low glass transition means that hydration and physical aging can alter mechanical properties before significant mass loss. In a 37 °C aqueous environment, a device can absorb water, plasticize, and lose stiffness while molecular weight declines. This is why strength-retention studies should be conducted under ISO 527-2:2012 or ASTM D638 using aged specimens, not room-temperature dry specimens. The sequence distribution also affects solubility in organic solvents; chlorinated solvents and ethyl acetate are common solvents for solution processing, while acetone and short-chain alcohols are poor solvents for this lactide-rich grade.

Sterilization Compatibility and Packaging Restrictions

Ethylene oxide sterilization according to ISO 11135:2014 is generally compatible when residual gas and humidity levels are controlled. Gamma and electron-beam sterilization under ISO 11137-2:2013 induce chain scission in lactide-glycolide copolymers; radiation-induced molecular weight loss is dose-dependent and can shift the degradation timeline. Typical terminal sterilization doses of 15–25 kGy require post-sterilization inherent-viscosity testing to establish whether the device remains within its qualified mechanical window. If gamma sterilization is selected, the oxygen-permeable packaging atmosphere and irradiation temperature should be controlled because radical recombination and oxidation compete with chain scission.

The original packaging is usually an aluminum-lined foil laminate sealed under vacuum or dry nitrogen. Once opened, the granulate should be re-dried if not used immediately, especially in environments above 60% relative humidity. Transfer from cold storage to room temperature without allowing the package to equilibrate inside a dry environment can cause condensation on granule surfaces. The product is not compatible with moisture-permeable bulk containers for long-term storage.

For device-specific validation, process analytical monitoring should include melt temperature, melt pressure, screw speed, and post-process inherent viscosity. Lot-to-lot comparisons are more reliable when measured on the same dilute-solution viscometer and after standardized drying because moisture and thermal history affect apparent viscosity. In-line rheometers may be used during compounding to track polymer degradation but require calibration against off-line ISO 1628-1:2021 values. If the granulate is compounded with radiopaque fillers such as barium sulfate or calcium carbonate, the filler content and particle size distribution should be specified because these additives alter melt viscosity and surface roughness; biocompatibility of the filled compound must be evaluated separately from the base polymer.